Comparison of the Efficacy of Inhaled Versus Infused Milrinone in the Management of Persistent Pulmonary Hypertension of the Newborn in Resource‐limited Settings: A Randomized Clinical Trial

Farhad Abolhasan Choobdar,Peyman Shahhosseini,Zahra Vahedi,Nastaran Khosravi,Nasrin Khalesi,Maral Ghassemzadeh

Pediatric pulmonology（2023）

Cited 0|Views6
No score
Abstract
The standard treatment for persistent pulmonary hypertension of the newborn (PPHN) is inhaled nitric oxide (iNO), which is not available in Iran. Consequently, other drugs, such as milrinone, are prescribed. So far, no study has investigated the effectiveness of inhaled milrinone in the management of PPHN. The present study aimed to improve the management of PPHN in the absence of iNO.
More
Translated text
Key words
neonates,oxygenation,persistent fetal circulation syndrome,pulmonary artery hypertension,respiratory distress
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined